JPRN-UMIN000003704尚未招募未知
Clinical study on usefulness of PGA and fibrin glue covering for oral mucosal defect - covering method with PGA for oral mucosal defect
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1,A patient who do not agree with the cooperation of the study. 2,The material used in the study is contraindicated in the patient.
研究者
相似试验
已完成
不适用
Efficacy of polyglycolic acid sheets and fibrin glue for patients with continuous low-dose aspiriThe indicated lesion for gastric ESD with continuous use of aspirinJPRN-UMIN000026051ew Tokyo Hospital80
尚未招募
不适用
Clinical evaluations of autologous fibrin glue and polyglycolic acid sheets as preventing esophageal stricture after endoscopic submucosal dissection of superficial esophageal neoplasmssuperficial esophageal neoplasmsJPRN-UMIN000027336Toranomon Hospital30
招募中
2 期
Investigating the effect of repairing gel and platelet-fibrin glue in the healing of woundsIRCT20191228045924N5Mashhad University of Medical Sciences40
已完成
3 期
The effect of local fibrinogen administration on postoperative bleeding in CABG patientscoronary artery bypass graft.Atherosclerotic heart diseaseIRCT201510222804N9Vice chancellor for research, Shahid Beheshti University of Medical Sciences50
进行中(未招募)
1 期
se of fibrinogen in the treatment of bleeding in thrombopenic patients after intensive chemotherapy refractory to platelet transfusio- Major patient- Patient with malignant hemopathy requiring intensive chemotherapy, autologous or allogeneic hematopoietic stem cell transplantation- Grade = 1 hemorrhagic symptom according to WHO - WHO classification- Body weight between 38 and 78 kg- Patient presenting with a platelet refractory state defined according to the Corrected Count Increment (CCI)- Patient affiliated to a social security schemeMedDRA version: 21.1Level: LLTClassification code 10066481Term: Hematological malignancySystem Organ Class: 100000004864EUCTR2021-000990-10-FRInstitut de Cancérologie Lucien Neuwirth10
